[1] C. S. Ahuja et al., “Traumatic spinal cord injury,” Nature Reviews Disease Primers, vol. 3. Nature Publishing Group, Apr. 27, 2017. doi: 10.1038/nrdp.2017.18.
[2] M. J. Eckert and M. J. Martin, “Trauma: Spinal Cord Injury,” Surgical Clinics of North America, vol. 97, no. 5. W.B. Saunders, pp. 1031–1045, Oct. 01, 2017. doi: 10.1016/j.suc.2017.06.008.
[3] K. K. Wang et al., “An update on diagnostic and prognostic biomarkers for traumatic brain injury,” Expert Review of Molecular Diagnostics, vol. 18, no. 2. Taylor and Francis Ltd, pp. 165–180, Feb. 01, 2018. doi: 10.1080/14737159.2018.1428089.
[4] S. Mondello et al., “αiI-spectrin breakdown products (SBDPs): Diagnosis and outcome in severe traumatic brain injury patients,” Journal of Neurotrauma, vol. 27, no. 7, pp. 1203–1213, Jul. 2010, doi: 10.1089/neu.2010.1278.
[5] Z. Yang et al., “Temporal Profile and Severity Correlation of a Panel of Rat Spinal Cord Injury Protein Biomarkers,” Molecular Neurobiology, vol. 55, no. 3, pp. 2174–2184, Mar. 2018, doi: 10.1007/s12035-017-0424-7.
[6] S. Yokobori et al., “Acute diagnostic biomarkers for spinal cord injury: Review of the literature and preliminary research report,” World Neurosurgery, vol. 83, no. 5. Elsevier Inc., pp. 867–878, May 01, 2015. doi: 10.1016/j.wneu.2013.03.012.
[7] B. K. Kwon et al., “Cerebrospinal fluid biomarkers to stratify injury severity and predict outcome in human traumatic spinal cord injury,” Journal of Neurotrauma, vol. 34, no. 3, pp. 567–580, Feb. 2017, doi: 10.1089/neu.2016.4435.
[8] M. H. Pouw et al., “Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: A descriptive analysis of 16 subjects,” Spinal Cord, vol. 52, no. 6, pp. 428–433, 2014, doi: 10.1038/sc.2014.26.
[9] R. Ahadi, F. Khodagholi, A. Daneshi, A. Vafaei, A. A. Mafi, and M. Jorjani, “Diagnostic Value of Serum Levels of GFAP, pNF-H, and NSE Compared with Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury,” Spine, vol. 40, no. 14, pp. E823–E830, Jul. 2015, doi: 10.1097/BRS.0000000000000654.
[10] W. Du et al., “The prognostic value of serum neuron specific enolase (NSE) and s100b level in patients of acute spinal cord injury,” Medical Science Monitor, vol. 24, pp. 4510–4515, Jun. 2018, doi: 10.12659/MSM.907406.
[11] S. J. Lee et al., “Elevated serum S100B levels in acute spinal fracture without head injury,” Emergency Medicine Journal, vol. 27, no. 3, pp. 209–212, Mar. 2010, doi: 10.1136/emj.2008.063743.
[12] G. Shaw et al., “Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury,” Biochemical and Biophysical Research Communications, vol. 336, no. 4, pp. 1268–1277, Nov. 2005, doi: 10.1016/j.bbrc.2005.08.252.
[13] N. J. Olby et al., “Time course and prognostic value of serum GFAP, pNFH, and S100β concentrations in dogs with complete spinal cord injury because of intervertebral disc extrusion,” Journal of Veterinary Internal Medicine, vol. 33, no. 2, pp. 726–734, Mar. 2019, doi: 10.1111/jvim.15439.
[14] Y. Tang et al., “Serum and cerebrospinal fluid tau protein level as biomarkers for evaluating acute spinal cord injury severity and motor function outcome,” Neural Regeneration Research, vol. 14, no. 5, pp. 896–902, May 2019, doi: 10.4103/1673-5374.249238.
[15] T. Dalkilic et al., “Predicting Injury Severity and Neurological Recovery after Acute Cervical Spinal Cord Injury: A Comparison of Cerebrospinal Fluid and Magnetic Resonance Imaging Biomarkers,” Journal of Neurotrauma, vol. 35, no. 3, pp. 435–445, Feb. 2018, doi: 10.1089/neu.2017.5357.
[16] B. K. Kwon et al., “Neurochemical biomarkers in spinal cord injury,” Spinal Cord, vol. 57, no. 10. Nature Publishing Group, pp. 819–831, Oct. 01, 2019. doi: 10.1038/s41393-019-0319-8.
[17] B. K. Kwon et al., “Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury,” Journal of Neurotrauma, vol. 27, no. 4, pp. 669–682, Apr. 2010, doi: 10.1089/neu.2009.1080.
[18] A. Winnerkvist et al., “Multilevel somatosensory evoked potentials and cerebrospinal proteins: indicators of spinal cord injury in thoracoabdominal aortic aneurysm surgery,” European Journal of Cardio-thoracic Surgery, vol. 31, no. 4, pp. 637–642, Apr. 2007, doi: 10.1016/j.ejcts.2007.01.007.
[19] M. Guéz, C. Hildingsson, L. Rosengren, K. Karlsson, and G. Toolanen, “Nervous tissue damage markers in cerebrospinal fluid after cervical spine injuries and whiplash trauma,” Journal of Neurotrauma, vol. 20, no. 9, pp. 853–858, Sep. 2003, doi: 10.1089/089771503322385782.
[20] J. Kuhle et al., “Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 86, no. 3, pp. 273–279, Mar. 2015, doi: 10.1136/jnnp-2013-307454.